Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock

Muhammad Furqan; Yamei Chen; Akintunde Akinleye; Judy Sarungbam; Alan Gass; Karen Seiter; Delong Liu

doi:10.1007/s11684-014-0319-1

Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock

Muhammad Furqan, Yamei Chen, Akintunde Akinleye, Judy Sarungbam, Alan Gass, Karen Seiter, Delong Liu

Pathology

Research output: Contribution to journal › Article › peer-review

Abstract

Mantle cell lymphoma is an aggressive subtype of B cell non-Hodgkin lymphoma. It can progress to leukemic phase but frank leukemic picture at initial presentation is not common. Leukemic phase indicates advance stage of the disease and generally associated with extensive extra-nodal involvement. Pericardial invasion has been reported, however we could not find a report of myocardial infiltration by this disease since the appraisal of the term "mantle cell lymphoma" in 1992. Here we report a case of cardiac involvement by mantle cell leukemia leading to cardiogenic shock which complicates the treatment decisions.

Original language	English (US)
Pages (from-to)	254-258
Number of pages	5
Journal	Frontiers of Medicine in China
Volume	8
Issue number	2
DOIs	https://doi.org/10.1007/s11684-014-0319-1
State	Published - Jun 2014

Keywords

bendamustine
cardiogenic shock
mantle cell lymphoma

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/s11684-014-0319-1

Cite this

@article{1a862e9bf528469eb788302331461c8e,

title = "Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock",

abstract = "Mantle cell lymphoma is an aggressive subtype of B cell non-Hodgkin lymphoma. It can progress to leukemic phase but frank leukemic picture at initial presentation is not common. Leukemic phase indicates advance stage of the disease and generally associated with extensive extra-nodal involvement. Pericardial invasion has been reported, however we could not find a report of myocardial infiltration by this disease since the appraisal of the term {"}mantle cell lymphoma{"} in 1992. Here we report a case of cardiac involvement by mantle cell leukemia leading to cardiogenic shock which complicates the treatment decisions.",

keywords = "bendamustine, cardiogenic shock, mantle cell lymphoma",

author = "Muhammad Furqan and Yamei Chen and Akintunde Akinleye and Judy Sarungbam and Alan Gass and Karen Seiter and Delong Liu",

note = "Funding Information: Yamei Chen is supported by a grant from Xiamen Zhongshan Hospital, Fujian, China and by NYMC Blood Disease Fund.",

year = "2014",

month = jun,

doi = "10.1007/s11684-014-0319-1",

language = "English (US)",

volume = "8",

pages = "254--258",

journal = "Frontiers of Medicine in China",

issn = "1673-7342",

publisher = "Springer Science + Business Media",

number = "2",

}

TY - JOUR

T1 - Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock

AU - Furqan, Muhammad

AU - Chen, Yamei

AU - Akinleye, Akintunde

AU - Sarungbam, Judy

AU - Gass, Alan

AU - Seiter, Karen

AU - Liu, Delong

N1 - Funding Information: Yamei Chen is supported by a grant from Xiamen Zhongshan Hospital, Fujian, China and by NYMC Blood Disease Fund.

PY - 2014/6

Y1 - 2014/6

N2 - Mantle cell lymphoma is an aggressive subtype of B cell non-Hodgkin lymphoma. It can progress to leukemic phase but frank leukemic picture at initial presentation is not common. Leukemic phase indicates advance stage of the disease and generally associated with extensive extra-nodal involvement. Pericardial invasion has been reported, however we could not find a report of myocardial infiltration by this disease since the appraisal of the term "mantle cell lymphoma" in 1992. Here we report a case of cardiac involvement by mantle cell leukemia leading to cardiogenic shock which complicates the treatment decisions.

AB - Mantle cell lymphoma is an aggressive subtype of B cell non-Hodgkin lymphoma. It can progress to leukemic phase but frank leukemic picture at initial presentation is not common. Leukemic phase indicates advance stage of the disease and generally associated with extensive extra-nodal involvement. Pericardial invasion has been reported, however we could not find a report of myocardial infiltration by this disease since the appraisal of the term "mantle cell lymphoma" in 1992. Here we report a case of cardiac involvement by mantle cell leukemia leading to cardiogenic shock which complicates the treatment decisions.

KW - bendamustine

KW - cardiogenic shock

KW - mantle cell lymphoma

UR - http://www.scopus.com/inward/record.url?scp=84901642408&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901642408&partnerID=8YFLogxK

U2 - 10.1007/s11684-014-0319-1

DO - 10.1007/s11684-014-0319-1

M3 - Article

C2 - 24627286

AN - SCOPUS:84901642408

SN - 1673-7342

VL - 8

SP - 254

EP - 258

JO - Frontiers of Medicine in China

JF - Frontiers of Medicine in China

IS - 2

ER -

Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this